Sorafenib Plus hepatic arterial infusion of Oxaliplatin, Fluorouracil, and Leucovorin vs Sorafenib alone for Hepatocellular Carcinoma with Portal Vein Invasion: a Randomized Clinical Trial
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.